Roivant Sciences Ltd.
Recent Filings
All 886 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 144 | — | Mar 26, 2026 |
| 4 | FORM 4 | Mar 24, 2026 |
| 4 | FORM 4 | Mar 24, 2026 |
| 8-K/A | 8-K/A | Mar 23, 2026 |
| 4 | FORM 4 | Mar 19, 2026 |
| 4 | FORM 4 | Mar 18, 2026 |
| 144 | — | Mar 17, 2026 |
| 144 | — | Mar 16, 2026 |
| SCHEDULE 13G/A | — | Mar 6, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Torti Frank | President and Vant Chair | Award / Grant | 175,380 @ $22.45 | 13,911,927 | Dec 24, 2025 |
| Gold Daniel Allen | — | Sale | 432,718 @ $23.05 | 16,697,727 | Dec 17, 2025 |
| MANCHESTER KEITH S | — | Sale | 155,076 @ $23.02 | 16,542,651 | Dec 16, 2025 |
| QVT Financial LP | — | Sale | 155,076 @ $23.02 | 16,542,651 | Dec 16, 2025 |
| Ramaswamy Vivek | — | Sale | 1,975,858 @ $21.96 | 36,350,621 | Dec 11, 2025 |
| Venker Eric | President & Immunovant CEO | Sale | 200,000 @ $20.85 | 1,497,908 | Dec 9, 2025 |
| MANCHESTER KEITH S | — | Sale | 175,000 @ $20.24 | 18,047,727 | Nov 19, 2025 |
| Gold Daniel Allen | — | Sale | 850,000 @ $20.25 | 18,497,727 | Nov 19, 2025 |
| QVT Financial LP | — | Sale | 150,000 @ $20.20 | 18,347,727 | Nov 19, 2025 |
| Ramaswamy Vivek | — | Sale | 1,027,670 @ $20.33 | 34,193,406 | Nov 17, 2025 |